Unity Biotechnology

UBX

Unity Biotechnology is a startup biotechnology company that develops drugs which target senescent cells.The company's products in development include UBX0101, targeting knee osteoarthritis (in Phase I clinical trials as of June 2018), and UBX1967, a preclinical product targeting ophthalmologic disea …

Insider trades and stock quote 2023-2025

All insider trades at Unity Biotechnology

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
4/2/2025 SellGhosh, Anirvan Chief Executive Officer $1.0 $99,701
4/2/2025 SellSullivan, Lynne Marie CFO & Head of Corp. Dev. $1.0 $22,523
4/2/2025 SellNguyen, Alexander Hieu CLO and Head of Ops $1.0 $18,388
3/27/2025 SellNguyen, Alexander Hieu CLO and Head of Ops $1.2 $2,267
2/4/2025 SellGhosh, Anirvan Chief Executive Officer $2.2 $1,432
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)